| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.12▼ | 2.12▼ | 2.11▲ | 2.00▲ | 2.05▲ |
| MA10 | 2.13▼ | 2.10▲ | 2.08▲ | 1.95▲ | 1.97▲ |
| MA20 | 2.13▼ | 2.08▲ | 2.07▲ | 2.07▲ | 1.80▲ |
| MA50 | 2.10▲ | 2.04▲ | 1.98▲ | 1.97▲ | 1.85▲ |
| MA100 | 2.08▲ | 1.98▲ | 2.00▲ | 1.81▲ | 1.74▲ |
| MA200 | 2.07▲ | 2.02▲ | 2.05▲ | 1.93▲ | 3.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.004▲ | 0.004▲ | -0.002▼ | 0.029▲ |
| RSI | 43.960▼ | 58.735▲ | 59.401▲ | 56.696▲ | 57.180▲ |
| STOCH | 27.778 | 90.152▲ | 85.268▲ | 44.017 | 57.201 |
| WILL %R | -100.000▼ | -20.690▲ | -17.647▲ | -35.632 | -30.435 |
| CCI | -208.737▼ | 76.586 | 118.447▲ | 64.723 | 97.536 |
|
Tuesday, May 12, 2026 06:48 AM
Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for oral presentations at the 2026 ...
|
|
Friday, May 08, 2026 10:49 AM
Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, May 07, 2026 02:38 PM
Achieved alignment with FDA on pivotal ANTLER-3 trial design for vispa-cel in 2L LBCL -- -- Longer follow up on vispa-cel phase 1 clinical data expected at medical conference in 2026 -- -- CaMMouflage ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/05/26 | 1.995 | 2.14 | 1.995 | 2.11 | 1,631,922 |
| 12/05/26 | 2.04 | 2.08 | 1.965 | 2.03 | 1,762,455 |
| 11/05/26 | 1.97 | 2.185 | 1.9546 | 2.03 | 1,891,311 |
| 08/05/26 | 1.90 | 1.985 | 1.89 | 1.94 | 892,097 |
| 07/05/26 | 1.95 | 1.955 | 1.845 | 1.88 | 1,668,434 |
| 06/05/26 | 1.95 | 1.97 | 1.925 | 1.95 | 985,878 |
| 05/05/26 | 1.95 | 1.985 | 1.89 | 1.93 | 992,511 |
| 04/05/26 | 1.85 | 1.97 | 1.85 | 1.91 | 1,258,164 |
| 01/05/26 | 1.91 | 1.91 | 1.83 | 1.87 | 1,136,737 |
| 30/04/26 | 1.93 | 1.955 | 1.8401 | 1.88 | 1,024,315 |
|
|
||||
|
|
||||
|
|